These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12749892)

  • 1. N-isonicotinoyl-(L)-4-aminophenylalanine derivatives as tight binding VLA-4 antagonists.
    Doherty GA; Yang GX; Borges E; Tong S; McCauley ED; Treonz KM; Van Riper G; Pacholok S; Si Q; Koo GC; Shah K; Mumford RA; Hagmann WK
    Bioorg Med Chem Lett; 2003 Jun; 13(11):1891-5. PubMed ID: 12749892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Tetrahydrofuroyl-(L)-phenylalanine derivatives as potent VLA-4 antagonists.
    Yang GX; Chang LL; Truong Q; Doherty GA; Magriotis PA; de Laszlo SE; Li B; MacCoss M; Kidambi U; Egger LA; McCauley E; Van Riper G; Mumford RA; Schmidt JA; Hagmann WK
    Bioorg Med Chem Lett; 2002 Jun; 12(11):1497-500. PubMed ID: 12031328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-(3-phenylsulfonyl-3-piperidinoyl)-phenylalanine derivatives as potent, selective VLA-4 antagonists.
    Gutteridge CE; de Laszlo SE; Kamenecka TM; McCauley E; van Riper G; Mumford RA; Kidambi U; Egger LA; Tong S; Hagmann WK
    Bioorg Med Chem Lett; 2003 Mar; 13(5):885-90. PubMed ID: 12617914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substituted tetrahydrofuroyl-1-phenylalanine derivatives as potent and specific VLA-4 antagonists.
    Doherty GA; Yang GX; Borges E; Chang LL; MacCoss M; Tong S; Kidambi U; Egger LA; McCauley E; Van Riper G; Mumford RA; Schmidt JA; Hagmann WK
    Bioorg Med Chem Lett; 2002 Jun; 12(11):1501-5. PubMed ID: 12031329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Aroyl-L-phenylalanine derivatives as VCAM/VLA-4 antagonists.
    Sidduri A; Tilley JW; Lou JP; Chen L; Kaplan G; Mennona F; Campbell R; Guthrie R; Huang TN; Rowan K; Schwinge V; Renzetti LM
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2479-82. PubMed ID: 12161162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Cycloalkanoyl-L-phenylalanine derivatives as VCAM/VLA-4 antagonists.
    Sidduri A; Tilley JW; Hull K; Lou JP; Kaplan G; Sheffron A; Chen L; Campbell R; Guthrie R; Huang TN; Huby N; Rowan K; Schwinge V; Renzetti LM
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2475-8. PubMed ID: 12161161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dehydrophenylalanine derivatives as VLA-4 integrin antagonists.
    Porter JR; Archibald SC; Brown JA; Childs K; Critchley D; Head JC; Parton TA; Robinson MK; Shock A; Taylor RJ; Warrellow GJ
    Bioorg Med Chem Lett; 2003 Mar; 13(5):805-8. PubMed ID: 12617895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted N-(3,5-dichlorobenzenesulfonyl)-L-prolyl-phenylalanine analogues as potent VLA-4 antagonists.
    Kopka IE; Young DN; Lin LS; Mumford RA; Magriotis PA; MacCoss M; Mills SG; Van Riper G; McCauley E; Egger LE; Kidambi U; Schmidt JA; Lyons K; Stearns R; Vincent S; Colletti A; Wang Z; Tong S; Wang J; Zheng S; Owens K; Levorse D; Hagmann WK
    Bioorg Med Chem Lett; 2002 Feb; 12(4):637-40. PubMed ID: 11844689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-(arylacetyl)-biphenylalanines as potent VLA-4 antagonists.
    Li B; de Laszlo SE; Kamenecka TM; Kopka IE; Durette PL; Lanza T; MacCoss M; Tong S; Mumford RA; McCauley ED; Van Riper G; Schmidt JA; Hagmann WK
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2141-4. PubMed ID: 12127523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4.
    Okigami H; Takeshita K; Tajimi M; Komura H; Albers M; Lehmann TE; Rölle T; Bacon KB
    Eur J Pharmacol; 2007 Mar; 559(2-3):202-9. PubMed ID: 17234179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituted 3-amino biaryl propionic acids as potent VLA-4 antagonists.
    Kopka IE; Lin LS; Mumford RA; Lanza T; Magriotis PA; Young D; DeLaszlo SE; MacCoss M; Mills SG; Van Riper G; McCauley E; Lyons K; Vincent S; Egger LA; Kidambi U; Stearns R; Colletti A; Teffera Y; Tong S; Owens K; Levorse D; Schmidt JA; Hagmann WK
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2415-8. PubMed ID: 12161146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of N-{N-[(3-cyanobenzene) sulfonyl]-4(R)-(3,3-difluoropiperidin-1-yl)-(l)-prolyl}-4-[(3',5'-dichloro-isonicotinoyl) amino]-(l)-phenylalanine (MK-0617), a highly potent and orally active VLA-4 antagonist.
    Venkatraman S; Lebsack AD; Alves K; Gardner MF; James J; Lingham RB; Maniar S; Mumford RA; Si Q; Stock N; Treonze KM; Wang B; Zunic J; Munoz B
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5803-6. PubMed ID: 19713111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative structure activity relationship studies of piperazinyl phenylalanine derivatives as VLA-4/VCAM-1 inhibitors.
    Bhargava D; Karthikeyan C; Moorthy NS; Trivedi P
    Med Chem; 2009 Sep; 5(5):446-54. PubMed ID: 19534682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of N-{N-[(3-cyanophenyl)sulfonyl]-4(R)-cyclobutylamino-(L)-prolyl}-4-[(3',5'-dichloroisonicotinoyl) amino]-(L)-phenylalanine (MK-0668), an extremely potent and orally active antagonist of very late antigen-4.
    Lin LS; Lanza T; Jewell JP; Liu P; Jones C; Kieczykowski GR; Treonze K; Si Q; Manior S; Koo G; Tong X; Wang J; Schuelke A; Pivnichny J; Wang R; Raab C; Vincent S; Davies P; Maccoss M; Mumford RA; Hagmann WK
    J Med Chem; 2009 Jun; 52(11):3449-52. PubMed ID: 19441819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly constrained bicyclic VLA-4 antagonists.
    Chang LL; Truong Q; Doss GA; MacCoss M; Lyons K; McCauley E; Mumford R; Forrest G; Vincent S; Schmidt JA; Hagmann WK
    Bioorg Med Chem Lett; 2007 Feb; 17(3):597-601. PubMed ID: 17118652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and evaluation of N-(triazin-1,3,5-yl) phenylalanine derivatives as VLA-4 integrin antagonists.
    Porter JR; Archibald SC; Brown JA; Childs K; Critchley D; Head JC; Hutchinson B; Parton TA; Robinson MK; Shock A; Warrellow GJ; Zomaya A
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1591-4. PubMed ID: 12039569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A small molecule alpha4beta1/alpha4beta7 antagonist differentiates between the low-affinity states of alpha4beta1 and alpha4beta7: characterization of divalent cation dependence.
    Egger LA; Cao J; McCallum C; Kidambi U; Van Riper G; McCauley E; Mumford RA; Lanza TJ; Lin LS; de Laszlo SE; Young DN; Yang G; Dean DC; Raab CE; Wallace MA; Jones AN; Hagmann WK; Schmidt JA; Pepinsky RB; Scott DM; Lee WC; Cornebise MA; Detmers PA
    J Pharmacol Exp Ther; 2003 Sep; 306(3):903-13. PubMed ID: 12766251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-(pyrimidin-4-yl) and N-(pyridin-2-yl) phenylalanine derivatives as VLA-4 integrin antagonists.
    Porter JR; Archibald SC; Brown JA; Childs K; Critchley D; Head JC; Hutchinson B; Parton TA; Robinson MK; Shock A; Warrellow GJ; Zomaya A
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1595-8. PubMed ID: 12039570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-benzylpyroglutamyl-L-phenylalanine derivatives as VCAM/VLA-4 antagonists.
    Chen L; Tilley JW; Guthrie RW; Mennona F; Huang TN; Kaplan G; Trilles R; Miklowski D; Huby N; Schwinge V; Wolitzky B; Rowan K
    Bioorg Med Chem Lett; 2000 Apr; 10(8):729-33. PubMed ID: 10782674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.